|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kato M and Asaka M: Recent knowledge of
the relationship between Helicobacter pylori and gastric
cancer and recent progress of gastroendoscopic diagnosis and
treatment for gastric cancer. Jpn J Clin Oncol. 40:828–837. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Li L, Ying XJ, Sun TT, Yi K, Tian HL, Sun
R, Tian JH and Yang KH: Overview of methodological quality of
systematic reviews about gastric cancer risk and protective
factors. Asian Pac J Cancer Prev. 13:2069–2079. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Deng Z, Ma S, Zhou H, Zang A, Fang Y, Li
T, Shi H, Liu M, Du M, Taylor PR, et al: Tyrosine phosphatase SHP-2
mediates C-type lectin receptor-induced activation of the kinase
Syk and anti-fungal TH17 responses. Nat Immunol. 16:642–652. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chung C: Tyrosine kinase inhibitors for
epidermal growth factor receptor gene mutation-positive non-small
cell lung cancers: An update for recent advances in therapeutics. J
Oncol Pharm Pract. 22:461–476. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Shabani M, Naseri J and Shokri F: Receptor
tyrosine kinase-like orphan receptor 1: A novel target for cancer
immunotherapy. Expert Opin Ther Targets. 19:941–955. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hatanpaa KJ, Burma S, Zhao D and Habib AA:
Epidermal growth factor receptor in glioma: Signal transduction,
neuropathology, imaging, and radioresistance. Neoplasia.
12:675–684. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mellinghoff IK, Wang MY, Vivanco I,
Haas-Kogan DA, Zhu S, Dia EQ, Lu KV, Yoshimoto K, Huang JH, Chute
DJ, et al: Molecular determinants of the response of glioblastomas
to EGFR kinase inhibitors. N Engl J Med. 353:2012–2024. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mizukami T, Togashi Y, Sogabe S, Banno E,
Terashima M, De Velasco MA, Sakai K, Fujita Y, Tomida S, Nakajima
TE, et al: EGFR and HER2 signals play a salvage role in
MEK1-mutated gastric cancer after MEK inhibition. Int J Oncol.
47:499–505. 2015.PubMed/NCBI
|
|
10
|
Yk W, Cf G, Xw TYZCZ, Xx L, Nl M and Wz Z:
Assessment of ERBB2 and EGFR gene amplification and protein
expression in gastric carcinoma by immunohistochemistry and
fluorescence in situ hybridization. Mol Cytogenet. 4:142011.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu C, Smet A, Blaecher C, Flahou B,
Ducatelle R, Linden S and Haesebrouck F: Gastric de novo Muc13
expression and spasmolytic polypeptide-expressing metaplasia during
Helicobacter heilmannii infection. Infect Immun.
82:3227–3239. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Khan S, Ebeling MC, Zaman MS, Sikander M,
Yallapu MM, Chauhan N, Yacoubian AM, Behrman SW, Zafar N, Kumar D,
et al: MicroRNA-145 targets MUC13 and suppresses growth and
invasion of pancreatic cancer. Oncotarget. 5:7599–7609. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chauhan SC, Ebeling MC, Maher DM, Koch MD,
Watanabe A, Aburatani H, Lio Y and Jaggi M: MUC13 mucin augments
pancreatic tumorigenesis. Mol Cancer Ther. 11:24–33. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu G, Jiang C, Li D, Wang R and Wang W:
MiRNA-34a inhibits EGFR-signaling-dependent MMP7 activation in
gastric cancer. Tumour Biol. 35:9801–9806. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liu D, Xia P, Diao D, Cheng Y, Zhang H,
Yuan D, Huang C and Dang C: MiRNA-429 suppresses the growth of
gastric cancer cells in vitro. J Biomed Res. 26:389–393. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li C, Li JF, Cai Q, Qiu QQ, Yan M, Liu BY
and Zhu ZG: miRNA-199a-3p in plasma as a potential diagnostic
biomarker for gastric cancer. Ann Surg Oncol. 20:(Suppl 3).
S397–S405. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nardone RM: Curbing rampant
cross-contamination and misidentification of cell lines.
Biotechniques. 45:221–227. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yang F, Wang H, Jiang Z, Hu A, Chu L, Sun
Y and Han J: MicroRNA19a mediates gastric carcinoma cell
proliferation through the activation of nuclear factor-kB. Mol Med
Rep. 12:5780–5786. 2015.PubMed/NCBI
|
|
20
|
Liang CC, Park AY and Guan JL: In vitro
scratch assay: A convenient and inexpensive method for analysis of
cell migration in vitro. Nat Protoc. 2:329–333. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Khan S, Ansarullah D Kumar, Jaggi M and
Chauhan SC: Targeting microRNAs in pancreatic cancer: Microplayers
in the big game. Cancer Res. 73:6541–6547. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Luo H, Guo W, Wang F, You Y, Wang J, Chen
X, Wang J, Wang Y, Du Y, Chen X, et al: miR-1291 targets mucin 1
inhibiting cell proliferation and invasion to promote cell
apoptosis in esophageal squamous cell carcinoma. Oncol Rep.
34:2665–2673. 2015.PubMed/NCBI
|
|
23
|
Wakata K, Tsuchiya T, Tomoshige K, Takagi
K, Yamasaki N, Matsumoto K, Miyazaki T, Nanashima A, Whitsett JA,
Maeda Y and Nagayasu T: A favourable prognostic marker for EGFR
mutant non-small cell lung cancer: Immunohistochemical analysis of
MUC5B. BMJ Open. 5:e0083662015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Maher DM, Gupta BK, Nagata S, Jaggi M and
Chauhan SC: Mucin 13: Structure, function, and potential roles in
cancer pathogenesis. Mol Cancer Res. 9:531–537. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Arias-Romero LE and Chernoff J:
p21-activated kinases in Erbb2-positive breast cancer: A new
therapeutic target? Small GTPases. 1:124–128. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Moasser MM: The oncogene HER2: Its
signaling and transforming functions and its role in human cancer
pathogenesis. Oncogene. 26:6469–6487. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Han HS, Son SM, Yun J, Jo YN and Lee OJ:
MicroRNA-29a suppresses the growth, migration, and invasion of lung
adenocarcinoma cells by targeting carcinoembryonic antigen-related
cell adhesion molecule 6. FEBS Lett. 588:3744–3750. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sun S, Sun P, Wang C and Sun T:
Downregulation of microRNA-155 accelerates cell growth and invasion
by targeting c-myc in human gastric carcinoma cells. Oncol Rep.
32:951–956. 2014.PubMed/NCBI
|
|
29
|
Xia Y and Gao Y: MicroRNA-181b promotes
ovarian cancer cell growth and invasion by targeting LATS2. Biochem
Biophys Res Commun. 447:446–451. 2014. View Article : Google Scholar : PubMed/NCBI
|
